Drugs / Diphtheria，Tetanus and Acellular Pertussis Combined Vaccine，DTaP
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05951725 Comparator | Aug 2023 → Apr 2025 overdue | — | CanSino Biologics Inc. | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Diphtheria，Tetanus and Acellular Pertussis Combined Vaccine，DTaP | “Diphtheria，Tetanus and Acellular Pertussis Combined Vaccine，DTaP” NCT05951725 ↗ |
| Known as | DTaP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05951725 ↗ |